Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults

Journal of Neuro-Oncology

Volumn 89, Issue 3, 2008, Pages 313-337

  Buatti, John ^a   Ryken, Timothy C ^a   Smith, Mark C ^b   Sneed, Penny ^c   Suh, John H ^d   Mehta, Minesh ^e   Olson, Jeffrey J ^f  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; DACARBAZINE; IODINE 125; IRIDIUM 192; LOMUSTINE; PROCARBAZINE; SEMUSTINE; VINCRISTINE;

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; DOSIMETRY; EVIDENCE BASED MEDICINE; GLIOBLASTOMA; HUMAN; MEDICAL LITERATURE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION; TREATMENT INDICATION; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; RADIOTHERAPY;

EID: 50449110164     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9617-2     Document Type: Article

References (66)

1. Neuro-oncology Disease Site Group et al (2004) Radiotherapy for newly diagnosed malignant glioma in adults. Practice Guideline Report 9-3
2. Shapiro WR, Young DF (1976) Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch Neurol 33(7):494-550
3. Walker MD et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49(3):333-343
4. Walker MD et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 303(23):1323-1329
5. Kristiansen K et al (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649-652
6. Sandberg-Wollheim M et al (1991) A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68(1):22-29
7. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: A systematic review. Radiother Oncol 64(3):259-273
8. Andersen AP (1978) Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 17(6):475-484
9. Bleehen NM, Stenning SP (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64(4):769-774
10. Nelson DF et al (1993) Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma-possible advantage observed at 72.0 Gy in 1.2 Gy B·I.D. fractions: Report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys 25(2):193-207
11. Chang CH et al (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52(6):997-1007
12. Nelson DF et al (1988) Combined modality approach to treatment of malignant gliomas - reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 1988(6):279-284
13. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731
14. Lee S et al (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79-88
15. Massey V, Wallner K (1990) Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18:395-398
16. Wallner K et al (1989) Patterns of failure following treatment for glioblastoma and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409
17. Shapiro WR et al (1989) Randomized trial of three chemotherapy regimens, two radiotherapy regimens, two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71(1):1-9
18. Kita M et al (1989) Radiotherapy of malignant glioma-prospective randomized clinical study of whole brain vs. local irradiation. Gan No Rinsho 35(11):1289-1294
19. Phillips C et al (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68(1):23-26
20. Prados MD et al (2001) Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 49(1):71-77
21. Deutsch M et al (1989) Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. International Int J Rad Oncol Biol Phys 16(6):1389-1396
22. Ludgate CM et al (1988) Superfractionated radiotherapy in grade III, IV intracranial gliomas. Int J Rad Oncol Biol Phys 15(5):1091-1095
23. Shin KH et al (1985) Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 56(4):758-760
24. Fulton DS et al (1984) Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys 10:1709-1712
25. Shin KH, Muller PJ, Geggie PH (1983) Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 52(11):2040-2043
26. Payne DG et al (1982) Malignant astrocytoma: Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 50(11):2301-2306
27. Stuschke M, Thames HD (1997) Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 37(2):259-267
28. Kleinberg L et al (1997) Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Rad Oncol Biol Phys 38(1):31-36
29. Bauman GS et al (1994) A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Rad Oncol Biol Phys 29(4):835-839
30. Sultanem K et al (2004) The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 58(1):247-252
31. Roa W et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 22(9):1583-1588
32. Hulshof MC et al (2000) Hypofractionation in glioblastoma multiforme. Radiother Oncol 54(2):143-148
33. Ford JM et al (1997) A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol (R Coll Radiol) 9(1):20-24
34. Hoegler DB, Davey P (1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neuro-oncol 33(3):201-204
35. Slotman BJ et al (1996) Hypofractionated radiation therapy in patients with glioblastoma multiforme: Results of treatment and impact of prognostic factors. Int J Rad Oncol Biol Phys 34(4):895-898
36. Thomas R et al (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33(2):113-116
37. Glinski B (1993) Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial. J Neuro-oncol 16(2):167-172
38. Brada M et al (1999) Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. Int J Rad Oncol Biol Phys 43(2):287-292
39. Werner-Wasik M et al (1996) Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 77(8):1535-1543
40. Horiot JC et al (1988) European organization for research on treatment of cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey. Front Radiat Ther Oncol 22:149-161
41. Keim H et al (1987) Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiotherapy and Oncology: Radiother Oncol 9(1):21-26
42. Simpson WJ, Platts ME (1976) Fractionation study in the treatment of glioblastoma multiforme. International Int J Radiat Oncol Biol Phys 1(7-8):639-644
43. Wen PY et al (1994) Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 73(12):3029-3036
44. Sneed PK et al (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40(2):287-295
45. Sneed PK et al (1995) Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36(5):898-903 discussion 903-904
46. Chang CN et al (2003) High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes. J Neurooncol 61(1):45-55
47. Koot RW et al (2000) Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme. Cancer 88(12):2796-2802
48. Videtic GM et al (2001) Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 51(4):963-968
49. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis. Neuro Oncol 6(3):227-235
50. Laperriere NJ et al (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41(5):1005-1011
51. Selker RG et al (2002) The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51(2):343-355 discussion 355-357
52. Chang CN et al (2003) High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes. J Neurooncol 61(1):45-55
53. Mayr MT et al (2002) Results of interstitial brachytherapy for malignant brain tumors. Int J Oncol 21(4): 817-823
54. Curran WJ Jr et al (1993) Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyper-fractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11(5):857-862
55. Lustig RA, Scott CB, Curran WJ (2004) Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies? Am J Clin Oncol 27(5):516-521
56. Souhami L et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60(3):853-860
57. Masciopinto JE et al (1995) Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82(4):530-535
58. Gannett D et al (1995) Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 33(2):461-468
59. Buatti JM et al (1995) Linac radiosurgery for high-grade gliomas: The University of Florida experience. Int J Radiat Oncol Biol Phys 32(1):205-210
60. Mehta MP et al (1994) Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30(3):541-549
61. Kondziolka D et al (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41(4):776-783 discussion 783-785
62. Larson DA et al (1996) Gamma knife for glioma: Selection factors and survival. Int J Radiat Oncol Biol Phys 36(5):1045-1053
63. Sarkaria JN et al (1995) Radiosurgery in the initial management of malignant gliomas: Survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32(4): 931-941
64. Cho KH et al (2004) Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme. Technol Cancer Res Treat 3(1):41-49
65. Nwokedi EC et al (2002) Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50(1):41-46 discussion 46-47
66. Shrieve DC et al (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome. J Neurosurg 90(1):72-77